The nampt inhibitor fk866 in combination with cisplatin reduces cholangiocarcinoma cells growth

HIGHLIGHTS

  • who: Kishor Pant and collaborators from the The Hormel Institute, University of Minnesota, Austin, MN, USA have published the Article: The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth, in the Journal: Cells 2023, 12, 775. of 22/02/2023
  • what: The authors show herein that is expressed in CCA cells and suppresses the capacity of CCA cells to grow in a dose-dependent manner. At the University Hospital of Modena in Italy, each patient completed a general informed permission form authorizing the use of the data for research purposes and analysis . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?